5QK-13258-97796
1 vaccination
2 coded responses
14 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 201 / VA
- Registered
- 2022-07-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-07-18
Registered in v-safe
-
2022-07-18
Dose 1 — Janssen/Johnson & Johnson
- 2022-07-18
-
2022-07-19
Survey response — days 1–6 daily, dose 1MedDRA: Abdominal pain, Diarrhoea, Flatulence — Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, Abdominal painFree text: *slightly looser stool and extra gas, suspect that is the cause of the slight/mild abdominal painMedDRA releases: 2024-11 · check-in free text available
-
2022-07-20
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fatigue or tiredness, NauseaAdult check-in
-
2022-07-21
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Headache, Fatigue or tiredness, Abdominal painAdult check-in
-
2022-07-22
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Headache, NauseaAdult check-in
-
2022-07-23
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2022-07-24
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, NauseaAdult check-in
- 2022-07-25
-
2022-08-01
Survey response — day 14, dose 1MedDRA: Mycobacterium test positive, Uterine obstruction — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Abnormal afb blood test (high). Boys flow to uterus restricted on both sidesMedDRA releases: 2024-11 · check-in free text available
-
2022-08-01
Report sent to call center — day 14, dose 1Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-08-02
- 2022-08-08
- 2022-08-15
- 2022-08-24
- 2022-08-29
- 2022-10-19
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-07-18 | Janssen/Johnson & Johnson | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-08-01 | Unsuccessful |
Free text
Release 12 — days 1–6 daily, dose 1
Systemic reaction (other): *slightly looser stool and extra gas, suspect that is the cause of the slight/mild abdominal pain
Release 12 — day 14, dose 1
Symptoms: Abnormal afb blood test (high). Boys flow to uterus restricted on both sides
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Mycobacterium test positive | · | · | ✓ |
| SD | Uterine obstruction | · | · | ✓ |
| SRO | Abdominal pain | · | · | ✓ |
| SRO | Diarrhoea | · | · | ✓ |
| SRO | Flatulence | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release